|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-12.57/-5.50
|
Enterprise Value
1.88K
|
Balance Sheet |
Book Value Per Share
0.18
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
0
|
Operating Revenue Per Share
--
|
Industry Comparison
|
||||||||||||||||
|
Quotes are at least 15-min delayed:2024/10/31 19:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs). |